| Code | 1906F | ||||||||||
| MA number | 50/0389/25-S | ||||||||||
| Product Form: | tbl 200x250 mg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 50 - DIURETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 19.11.2025 |
| Validity: | 19.11.2030 |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Furon 125 mg 250 mg_11_2025.pdf
|
| SPC: |
SPC_Furon 125 mg 250 mg_11_2025.pdf
|
| Safety feature | Yes |
| Data update: | 20.11.2025 |
